Events
-
-
Grand Rounds June 10: Do We Really Need So Many Heart Failure Clinicians? (Tariq Ahmad, MD, MPH)
Speaker: Tariq Ahmad, MD, MPH Director, Cardiac Transplant and MCS Chief, Heart Failure Program Yale School of Medicine, Yale New Haven Health Topic: Do We Really Need So Many Heart Failure Clinicians? Date: Friday, June 10, 2022, 1:00-2:00 p.m. ET Meeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications […]
-
NIH Pragmatic Trials Collaboratory 2022 Annual Workshop Critical Questions for Pragmatic Clinical Trialists: Insights From the NIH Pragmatic Trials Collaboratory’s First Decade
The NIH Pragmatic Trials Collaboratory will hold a virtual workshop June 15-16, 2022, to explore questions critical to designing and implementing pragmatic clinical trials conducted within healthcare systems. This workshop […]
-
NIH Pragmatic Trials Collaboratory 2022 Annual Workshop Critical Questions for Pragmatic Clinical Trialists: Insights From the NIH Pragmatic Trials Collaboratory’s First Decade
The NIH Pragmatic Trials Collaboratory will hold a virtual workshop June 15-16, 2022, to explore questions critical to designing and implementing pragmatic clinical trials conducted within healthcare systems. This workshop […]
-
Grand Rounds June 17: PREPARE: A Successful, Primarily Remote Pragmatic Trial in a Black and Latinx Population With Asthma: Challenges and Successes (Elliot Israel, MD)
Speaker: Elliot Israel, M.D. Professor of Medicine Harvard Medical School Gloria M. and Anthony C. Simboli Distinguished Chair in Asthma Research Director of Clinical Research Pulmonary and Critical Care Division […]
-
Grand Rounds June 24: FDA Draft Guidance on Real-World Evidence (John Concato, MD, MS, MPH)
Speaker: John Concato, MD, MS, MPH Associate Director for Real-World Evidence Analytics Office of Medical Policy (OMP) Center for Drug Evaluation and Research (CDER) Food and Drug Administration (FDA) Topic: […]
-
-
Grand Rounds July 8: Results From the COVID-OUT Trial, a Phase-3 Trial of Outpatient Treatment for COVID-19 Using Metformin, Ivermectin, and Fluvoxamine (Carolyn Bramante, MD, MPH; Thomas Murray, PhD; Jaren Huling, PhD)
Speakers: Carolyn Bramante, MD, MPH Assistant Professor, General Internal Medicine and Pediatrics Core Faculty, Center for Pediatric Obesity Medicine Core Faculty, Program for Health Disparities Research University of Minnesota Medical […]
-
Grand Rounds July 15: Overview of Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Public-Private Partnership and Lessons Learned (Stacey J. Adam, PhD)
Speaker: Stacey J. Adam, PhD Associate Vice President, Research Partnerships Foundation for the NIH Topic: Overview of Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Public-Private Partnership and Lessons Learned […]
-
Grand Rounds July 22: ACTIV-6: One Year Later and Trial Results for Ivermectin-400 and Inhaled Fluticasone (Susanna Naggie, MD, MHS)
Speaker: Susanna Naggie, MD, MHS Professor of Medicine Vice Dean for Clinical Research Duke University School of Medicine Infectious Diseases Research Duke Clinical Research Institute Topic: ACTIV-6: 1-year Later […]
-
Grand Rounds July 29: Effect of Early Treatment With Single-Dose Pegylated Interferon Lambda Among Patients With COVID-19: Results From the TOGETHER Trial (Edward Mills, PhD, FRCP; Jeffrey S. Glenn, MD, PhD)
Speakers: Edward Mills, PhD, FRCP Professor Department of Health Research Methods, Evidence & Impact McMaster University, Canada Jeffrey S. Glenn, MD, PhD Joseph D. Grant Professor and Professor of Microbiology […]
-
-
Grand Rounds August 5: Economic Evaluation of Platform Trial Designs (Jay JH Park, PhD, MSc)
Speaker: Jay JH Park, PhD, MSc Assistant Professor Department of Health Research Methods, Evidence and Impact Faculty of Health Sciences McMaster University Topic: Economic Evaluation of Platform Trial Designs Date: […]